Skip to main content

Advertisement

Log in

The Longer-Term Effects of Roux-en-Y Gastric Bypass Surgery on Sodium Excretion

  • Clinical Research
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Obesity is an independent risk factor for hypertension and chronic kidney disease. During the first months after bariatric surgery, an improvement of sodium excretion has been described. The aim of this work was to study the influence of bariatric surgery on sodium excretion at more than a year after the intervention.

Methods

Patients who have undergone Roux-en-Y gastric bypass (RYGB) and who had collected a 24-h urine sample before surgery more than 12 months ago were asked to participate. A second 24-h urine sample was collected. Blood pressure and weight were measured. The difference in sodium excretion before and after surgery was calculated, and the relationship with blood pressure and weight loss was investigated.

Results

We included 33 patients; the median follow-up time was 21 months (range 14–41). Sodium excretion was high before surgery (median 195 mmol/day, IQR range 167–247) and decreased by 18 % after surgery (median 160 mmol/day, IQR range 118–205, p = 0.015), while there were significant improvements in body weight (% EWL 80.9 ± 21.8), systolic blood pressure (126 to 120 mmHg, p = 0.02), and diastolic blood pressure (84 to 77 mmHg, p = 0.002), even with a reduced number of antihypertensive drugs.

Conclusions

After RYGB and considerable weight loss, sodium excretion remains high in the longer term. The profound improvement in blood pressure cannot be explained by reductions in sodium excretion after RYGB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Garrett JR, McNolty LA. Bariatric surgery and the social character of the obesity epidemic. Am J Bioeth. 2010;10:20–2.

    PubMed  Google Scholar 

  2. Chen J, Gu D, Huang J, et al. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet. 2009;373:829–35.

    Article  PubMed  CAS  Google Scholar 

  3. Laville M. Renal consequences of obesity. Nephrol Ther. 2011;7:80–5.

    Article  PubMed  CAS  Google Scholar 

  4. Hall JE, Henegar JR, Dwyer TM, et al. Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther. 2004;11:41–54.

    Article  PubMed  Google Scholar 

  5. Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73:947–55.

    Article  PubMed  CAS  Google Scholar 

  6. Wu Y, Liu Z, Xiang Z, et al. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 2006;147:44–50.

    Article  PubMed  CAS  Google Scholar 

  7. Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Ren Physiol. 2000;278:F817–22.

    CAS  Google Scholar 

  8. Chagnac A, Herman M, Zingerman B, et al. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant. 2008;23:3946–52.

    Article  PubMed  CAS  Google Scholar 

  9. Cubeddu LX, Hoffmann IS, Aponte LM, et al. Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. Am J Hypertens. 2003;16:343–9.

    Article  PubMed  CAS  Google Scholar 

  10. Ritz E, Koleganova N, Piecha G. Is there an obesity–metabolic syndrome related glomerulopathy? Curr Opin Nephrol Hypertens. 2011;20:44–9.

    Article  PubMed  Google Scholar 

  11. Konta T, Hao Z, Abiko H, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int. 2006;70:751–6.

    Article  PubMed  CAS  Google Scholar 

  12. Verhave JC, Hillege HL, Burgerhof JG, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Int Med. 2004;256:324–30.

    Article  CAS  Google Scholar 

  13. Fujita T, Ando K. Role of electrolytes in the development and maintenance of hypertension. Nihon Naibunpi Gakkai Zasshi. 1994;70:423–30.

    PubMed  CAS  Google Scholar 

  14. Andersson OK, Fagerberg B, Hedner T. Importance of dietary salt in the hemodynamic adjustment to weight reduction in obese hypertensive men. Hypertension. 1984;6:814–9.

    Article  PubMed  CAS  Google Scholar 

  15. Kumanyika SK, Cook NR, Cutler JA, et al. Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. J Hum Hypertens. 2005;19:33–45.

    Article  PubMed  CAS  Google Scholar 

  16. Fagerberg B, Andersson OK, Isaksson B, et al. Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction. Br Med J (Clin Res Ed). 1984;288:11–4.

    Article  CAS  Google Scholar 

  17. Rissanen A, Pietinen P, Siljamaki-Ojansuu U, et al. Treatment of hypertension in obese patients: efficacy and feasibility of weight and salt reduction programs. Acta Med Scand. 1985;218:149–56.

    Article  PubMed  CAS  Google Scholar 

  18. van de Borne P, Watrin I, Bouquegneau M, et al. Ambulatory blood pressure and neuroendocrine control after diet-assisted gastric restrictive surgery. J Hypertens. 2000;18:301–6.

    Article  PubMed  Google Scholar 

  19. Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery. 2011;149:654–61.

    Article  PubMed  Google Scholar 

  20. Davis BR, Oberman A, Blaufox MD, et al. Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management. Am J Hypertens. 1994;7:926–32.

    PubMed  CAS  Google Scholar 

  21. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41:625–33.

    Article  PubMed  Google Scholar 

  22. Brown IJ, Tzoulaki I, Candeias V, et al. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38:791–813.

    Article  PubMed  Google Scholar 

  23. Michels WM, Grootendorst DC, Verduijn M, et al. Performance of the Cockcroft–Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5:1003–9.

    Article  PubMed  Google Scholar 

  24. Pekkarinen T, Takala I, Mustajoki P. Weight loss with very-low-calorie diet and cardiovascular risk factors in moderately obese women: one-year follow-up study including ambulatory blood pressure monitoring. Int J Obes Relat Metab Disord. 1998;22:661–6.

    Article  PubMed  CAS  Google Scholar 

  25. Caroline van den Hooven, Heidi Fransen, Eugene Jansen, Marga Ocke: 24-uurs urine-excretie van natrium, 2007 (Dutch). Retrieved from: www.rivm.nl.

  26. Powell CR, Stoller ML, Schwartz BF, et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000;55:825–30.

    Article  PubMed  CAS  Google Scholar 

  27. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–15.

    Article  PubMed  CAS  Google Scholar 

  28. Venezia A, Barba G, Russo O, et al. Dietary sodium intake in a sample of adult male population in southern Italy: results of the Olivetti Heart Study. Eur J Clin Nutr. 2010;64:518–24.

    Article  PubMed  CAS  Google Scholar 

  29. Zhang J, Temme EH, Sasaki S, et al. Under- and overreporting of energy intake using urinary cations as biomarkers: relation to body mass index. Am J Epidemiol. 2000;152:453–62.

    Article  PubMed  CAS  Google Scholar 

  30. Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4823–43.

    Article  PubMed  CAS  Google Scholar 

  31. Burge JC, Schaumburg JZ, Choban PS, et al. Changes in patients' taste acuity after Roux-en-Y gastric bypass for clinically severe obesity. J Am Diet Assoc. 1995;95:666–70.

    Article  PubMed  CAS  Google Scholar 

  32. Aoi W, Ueda Y, Tanigawa M. Effect of weight loss on the reduction of blood pressure in obesity hypertension—hyperinsulinemia and renal sodium retention. Nihon Jinzo Gakkai Shi. 1992;34:1177–82.

    PubMed  CAS  Google Scholar 

  33. Eliahou HE, Erdberg A, Blau A. Energy restriction or salt restriction in the treatment of overweight hypertension. Which one? A point of view. Clin Exp Hypertens A. 1990;12:795–802.

    Article  PubMed  CAS  Google Scholar 

  34. Navarro-Diaz M, Serra A, Romero R, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol. 2006;17:S213–7.

    Article  PubMed  Google Scholar 

  35. Ohashi H, Oda H, Ohno M, et al. Weight reduction improves high blood pressure and microalbuminuria in hypertensive patients with obesity. Nihon Jinzo Gakkai Shi. 2001;43:333–9.

    PubMed  CAS  Google Scholar 

  36. Serpa NA, Bianco Rossi FM, Dal Moro AR, et al. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J Nephrol. 2009;22:637–46.

    Google Scholar 

  37. Afshinnia F, Wilt TJ, Duval S, et al. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant. 2010;25:1173–83.

    Article  PubMed  Google Scholar 

  38. Agrawal V, Krause KR, Chengelis DL, et al. Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein. Surg Obes Relat Dis. 2009;5:20–6.

    Article  PubMed  Google Scholar 

  39. Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14:1480–6.

    Article  PubMed  Google Scholar 

  40. Serra A, Granada ML, Romero R, et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr. 2006;25:400–8.

    Article  PubMed  CAS  Google Scholar 

  41. Uzu T, Sakaguchi M, Yokomaku Y, et al. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker. Clin Exp Nephrol. 2009;13:300–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Funda Celik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Celik, F., Ahdi, M., Meesters, E.W. et al. The Longer-Term Effects of Roux-en-Y Gastric Bypass Surgery on Sodium Excretion. OBES SURG 23, 358–364 (2013). https://doi.org/10.1007/s11695-012-0764-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-012-0764-3

Keywords

Navigation